Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication-deficient vaccine vector (original) (raw)
Abstract
Lumpy skin disease virus (LSDV), a capripoxvirus with a host range limited to ruminants, was evaluated as a replication-deficient vaccine vector for use in non-ruminant hosts. By using the rabies virus glycoprotein (RG) as a model antigen, it was demonstrated that recombinant LSDV encoding the rabies glycoprotein (rLSDV-RG) was able to express RG in both permissive (ruminant) and non-permissive (non-ruminant) cells. The recombinant LSDV, however, replicated to maturity only in permissive but not in non-permissive cells. Recombinant LSDV-RG was assessed for its ability to generate immunity against RG in non-ruminant hosts (rabbits and mice). Rabbits inoculated with rLSDV-RG produced rabies virus (RV) neutralizing antibodies at levels twofold higher than those reported by the WHO to be protective. BALB/c mice immunized with rLSDV-RG elicited levels of RV-specific cellular immunity (T-cell proliferation) comparable with those of mice immunized with a commercial inactivated rabies vaccine (Verorab; Pasteur Merieux). Most importantly, mice immunized with rLSDV-RG were protected from an aggressive intracranial rabies virus challenge.
- Received: 22/01/2003
- Accepted:19/03/2003
- Published Online:01/08/2003
SGM
Article metrics loading...
/content/journal/jgv/10.1099/vir.0.19116-0
2003-08-01
2024-09-23
Full text loading...
/deliver/fulltext/jgv/84/8/vir841985.html?itemId=/content/journal/jgv/10.1099/vir.0.19116-0&mimeType=html&fmt=ahah
Most read this month
Article
content/journal/jgv
Journal
5
3
false
en